Karolinska Institutet is a leading Swedish medical university and the body responsible for awarding the Nobel Prize in Physiology or Medicine. NEC Labs America views Karolinska Institutet as a valuable collaborator in biomedical AI and cancer genomics. Joint research opportunities include digital pathology, single-cell RNA sequencing, and precision medicine. Such partnerships integrate cutting-edge medical research with NEC’s applied AI expertise for healthcare innovation.

Posts

Pathologist-Read vs AI-Driven Assessment of Tumor-Infiltrating Lymphocytes in Melanoma

/in /by

Tumor-infiltrating lymphocytes (TILs) are a provocative biomarker in melanoma, influencing diagnosis, prognosis, and immunotherapy outcomes; however, traditional pathologistreadTIL assessment on hematoxylin and eosin–stained slides is prone to interobserver variability, leading to inconsistent clinical decisions. Therefore, development of newer TIL scoring approachesthat produce more reliable and consistent readouts is important.

Read more